代谢干预措施以增强免疫治疗和向治疗在晚期结直肠癌中的疗效
Helena Oliveres1, Marta Cascante2, Joan Maurel3
1Medical Oncology Department, Hospital Clinic of Barcelona, Translational Genomics and Targeted Therapeutics in Solid Tumors Group, IDIBAPS, Barcelona, Spain.
Current opinion in chemical biology
|October 8, 2023
概括
本综述探讨了转移性结直肠癌 (mCRC) 中的免疫代谢相互作用. 一个新的签名 (IMMETCOLS) 可以指导个性化策略,以改善免疫治疗和针对性治疗在mCRC患者的疗效.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 代谢研究研究 代谢研究
背景情况:
- 目前的转移性结直肠癌 (mCRC) 治疗提供有限的益处,特别是在微卫星稳定 (MSS) 瘤.
- 虽然免疫疗法显示出前景,但其在MSS mCRC中的疗效仍然适度.
- 了解瘤代谢和免疫微环境之间的相互作用对于推进mCRC治疗至关重要.
研究的目的:
- 审查mCRC中癌细胞和免疫微环境之间的代谢相互作用.
- 探索瘤免疫/代谢特征和转录组亚型 (例如,共识分子亚型) 之间的相关性.
- 突出了针对个性化mCRC疗法的免疫代谢特征的需要.
主要方法:
- 文献综述侧重于mCRC中的免疫代谢相互作用.
- 分析瘤免疫,代谢和转录特征之间的相关性.
- 讨论现有的和新的预后/预测特征.
主要成果:
- 代谢重编程显著影响mCRC中的瘤免疫微环境.
- 特定的免疫代谢特征与转录基因分类相关,表明亚型特定的脆弱性.
- 一种新的免疫代谢特征 (IMMETCOLS) 显示了指导治疗策略的潜力.
结论:
- 瘤免疫微环境和癌细胞代谢在mCRC中密切相关.
- 免疫代谢签名为开发个性化治疗策略提供了一个有希望的途径.
- 该IMMETCOLS签名可以提高免疫疗法和针对性治疗在mCRC的疗效.
相关概念视频
Tumor Immunotherapy
544
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
544
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
178
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
178
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K


